Carrying a CYP2C19 mutation can impair drug metabolism. 15% of all prescribed drugs are metabolized by CYP2C19 enzymes, including anti-platelet drugs, anti-depressants and PPIs.
A third-party study of 325 individuals found that the Spartan RX CYP2C19 System was 100% sensitive and 100% specific compared to bi-directional DNA sequencing.
Printer included with system. User receives a results printout after the run is complete. No other analysis required.
Compact and lightweight. About the size of a shoebox. Easily fits into your existing workspace.
No pipetting. No DNA extraction. No complicated procedures. Just swab the patient's cheek and insert the sample into the tube.
Reimbursement available from Medicare and most insurers. CYP2C19 gene analysis of common variants for drug metabolism.
6,000-patient clinical trial entitled "Tailored Antiplatelet Initiation to Lessen Outcomes due to Clopidogrel Resistance after Percutaneous Coronary Interventions" (TAILOR PCI).